
EMBECTA CORP
EMBC · NASDAQ
Updated at 2026-10-15 06:44:56
- Today's High
- $6.25
- Today’s Low
- $6.11
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $6.19
- Previous Close
- $6.18
- Volume
- 651.46K
- Market Cap
- $350.15M
- P/E Ratio
- 4.00X
- EPS
- $1.47
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL INSTRUMENTS & SUPPLIES
- Headquarters
- 300 KIMBALL DRIVE, PARSIPPANY, NJ, UNITED STATES, 07054
- Country
- US
- Listing Date
- 2022-03-21
- Fiscal Year End
- September
- Shares Outstanding
- 59.33M
- CIK
- 0001872789
- Website
- www.embecta.com
Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management. Born from a spin-off of Becton, Dickinson and Company, Embecta provides a comprehensive portfolio of advanced products, including cutting-edge insulin pens and syringes tailored to improve patient outcomes. With a robust focus on operational excellence and customer satisfaction, Embecta is well-positioned to capitalize on growth opportunities in the rapidly expanding diabetes care market, strengthening its leadership in this vital sector.
Financial Metrics
Revenue
2026-06-30
$271.7M
2026-03-31
$221.8M
2025-12-31
$261.2M
2025-09-30
$264M
Operating Expenses
2026-06-30
$104.6M
2026-03-31
$82.3M
2025-12-31
$78.5M
2025-09-30
$91.6M
Net Income
2026-06-30
$21.1M
2026-03-31
-$4.1M
2025-12-31
$44.1M
2025-09-30
$26.4M
Net Profit Margin
2026-06-30
7.76%
2026-03-31
-1.84%
2025-12-31
16.88%
2025-09-30
10%
Earnings Per Share
2026-06-30
$0.56
2026-03-31
$0.27
2025-12-31
$0.71
2025-09-30
$0.50
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$64.7M
2026-03-31
$44.9M
2025-12-31
$95.9M
2025-09-30
$60.4M
Effective Tax Rate
2026-06-30
23.55%
2026-03-31
143.15%
2025-12-31
25.12%
2025-09-30
8.96%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $271.7M | $221.8M | $261.2M | $264M |
| Operating Expenses | $104.6M | $82.3M | $78.5M | $91.6M |
| Net Income | $21.1M | -$4.1M | $44.1M | $26.4M |
| Net Profit Margin | 7.76% | -1.84% | 16.88% | 10% |
| Earnings Per Share | $0.56 | $0.27 | $0.71 | $0.50 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $64.7M | $44.9M | $95.9M | $60.4M |
| Effective Tax Rate | 23.55% | 143.15% | 25.12% | 8.96% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.